314 related articles for article (PubMed ID: 20362962)
21. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
[TBL] [Abstract][Full Text] [Related]
22. FGFR1 mutations in Kallmann syndrome.
Villanueva C; de Roux N
Front Horm Res; 2010; 39():51-61. PubMed ID: 20389085
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome.
Tsai PS; Gill JC
Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):160-71. PubMed ID: 16932275
[TBL] [Abstract][Full Text] [Related]
24. Identification of two novel missense mutations in the KAL1 gene in Han Chinese subjects with Kallmann Syndrome.
Jap TS; Chiu CY; Lirng JF; Won GS
J Endocrinol Invest; 2011 Jan; 34(1):53-9. PubMed ID: 20530987
[TBL] [Abstract][Full Text] [Related]
25. Expanding the mutational spectrum of monogenic hypogonadotropic hypogonadism: novel mutations in ANOS1 and FGFR1 genes.
Gach A; Pinkier I; Szarras-Czapnik M; Sakowicz A; Jakubowski L
Reprod Biol Endocrinol; 2020 Jan; 18(1):8. PubMed ID: 31996231
[TBL] [Abstract][Full Text] [Related]
26. Molecular pathogenesis of Kallmann's syndrome.
Cadman SM; Kim SH; Hu Y; González-Martínez D; Bouloux PM
Horm Res; 2007; 67(5):231-42. PubMed ID: 17191030
[TBL] [Abstract][Full Text] [Related]
27. Kallmann syndrome: fibroblast growth factor signaling insufficiency?
Dodé C; Hardelin JP
J Mol Med (Berl); 2004 Nov; 82(11):725-34. PubMed ID: 15365636
[TBL] [Abstract][Full Text] [Related]
28. Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.
Leroy C; Fouveaut C; Leclercq S; Jacquemont S; Boullay HD; Lespinasse J; Delpech M; Dupont JM; Hardelin JP; Dodé C
Eur J Hum Genet; 2008 Jul; 16(7):865-8. PubMed ID: 18285834
[TBL] [Abstract][Full Text] [Related]
29. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
[TBL] [Abstract][Full Text] [Related]
30. The results of CHD7 analysis in clinically well-characterized patients with Kallmann syndrome.
Bergman JE; de Ronde W; Jongmans MC; Wolffenbuttel BH; Drop SL; Hermus A; Bocca G; Hoefsloot LH; van Ravenswaaij-Arts CM
J Clin Endocrinol Metab; 2012 May; 97(5):E858-62. PubMed ID: 22399515
[TBL] [Abstract][Full Text] [Related]
31. Isolated gonadotropic deficiency with and without anosmia: a developmental defect or a neuroendocrine regulation abnormality of the gonadotropic axis.
de Roux N
Horm Res; 2005; 64 Suppl 2():48-55. PubMed ID: 16286771
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetic and clinical delineation of 22 patients with congenital hypogonadotropic hypogonadism.
Aoyama K; Mizuno H; Tanaka T; Togawa T; Negishi Y; Ohashi K; Hori I; Izawa M; Hamajima T; Saitoh S
J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1111-1118. PubMed ID: 28915117
[TBL] [Abstract][Full Text] [Related]
33. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism.
Versiani BR; Trarbach E; Koenigkam-Santos M; Dos Santos AC; Elias LL; Moreira AC; Latronico AC; de Castro M
Clin Endocrinol (Oxf); 2007 Feb; 66(2):173-9. PubMed ID: 17223984
[TBL] [Abstract][Full Text] [Related]
34. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.
Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC
Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103
[TBL] [Abstract][Full Text] [Related]
35. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.
Laitinen EM; Tommiska J; Sane T; Vaaralahti K; Toppari J; Raivio T
PLoS One; 2012; 7(6):e39450. PubMed ID: 22724017
[TBL] [Abstract][Full Text] [Related]
36. Genetics of congenital hypogonadotropic hypogonadism in Denmark.
Tommiska J; Känsäkoski J; Christiansen P; Jørgensen N; Lawaetz JG; Juul A; Raivio T
Eur J Med Genet; 2014 Jul; 57(7):345-8. PubMed ID: 24732674
[TBL] [Abstract][Full Text] [Related]
37. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
Sarfati J; Dodé C; Young J
Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
[TBL] [Abstract][Full Text] [Related]
38. The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
Pedersen-White JR; Chorich LP; Bick DP; Sherins RJ; Layman LC
Mol Hum Reprod; 2008 Jun; 14(6):367-70. PubMed ID: 18463157
[TBL] [Abstract][Full Text] [Related]
39. Kallmann syndrome with FGFR1 and KAL1 mutations detected during fetal life.
Sarfati J; Bouvattier C; Bry-Gauillard H; Cartes A; Bouligand J; Young J
Orphanet J Rare Dis; 2015 Jun; 10():71. PubMed ID: 26051373
[TBL] [Abstract][Full Text] [Related]
40. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
Kim HG; Kurth I; Lan F; Meliciani I; Wenzel W; Eom SH; Kang GB; Rosenberger G; Tekin M; Ozata M; Bick DP; Sherins RJ; Walker SL; Shi Y; Gusella JF; Layman LC
Am J Hum Genet; 2008 Oct; 83(4):511-9. PubMed ID: 18834967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
